Tanner M Johanns

8PUBLICATIONS
89CO-AUTHORS
Predictive and prognostic markersNanomedicineCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 10, 2026
Automating neoantigen selection for personalized cancer vaccine design.

|May 12, 2026
Adjuvant personalized multivalent neoantigen DNA vaccination for MGMT unmethylated glioblastoma: a phase 1 trial.

|Mar 25, 2026
NT-I7, a Long-Acting Interleukin 7, Increases Lymphocyte Counts and Induces CD8+ T-cell Clonotype Expansion in Patients with Newly Diagnosed High-Grade Gliomas.

Omar H Butt, Kartik Singhal, Jingqin Luo

|Apr 19, 2024
Integrating Multisector Molecular Characterization into Personalized Peptide Vaccine Design for Patients with Newly Diagnosed Glioblastoma.

Tanner M Johanns, Elizabeth A R Garfinkle, Katherine E Miller

|Feb 28, 2024
Glioblastoma-Infiltrating CD8+ T Cells Are Predominantly a Clonally Expanded GZMK+ Effector Population.

Anthony Z Wang, Bryce L Mashimo, Maximilian O Schaettler

|Apr 07, 2023
Computational prediction of MHC anchor locations guides neoantigen identification and prioritization.

Huiming Xia, Joshua McMichael, Michelle Becker-Hapak

Pageof 2

Frequent Collaborators

5 joint publications

Obi L Griffith

5 joint publications

Malachi Griffith

3 joint publications

Maximilian O Schaettler

3 joint publications

Michael R Chicoine